News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
It all started with an email: The Tubulis story behind the 5 billion dollar exit
In June 2016, Jonas Helma-Smets writes an email. Politely worded, almost hesitant. He introduces himself, explains his idea, and asks for support. No funding, no infrastructure, no guarantee that anyone will be interested at all. Ten years later, this very idea becomes one of Europe’s biggest biotech exits: U.S. pharmaceutical company Gilead acquires Munich-based biotech startup Tubulis for up to five billion US dollars. Munich Startup spoke with people who accompanied the journey.
Tubulis acquired by American pharma giant
Munich-based biotech unicorn Tubulis is being acquired by US company Gilead for a multibillion-euro amount.
Flyla takes off with new CEO
Travel startup Flyla has a new CEO: Vladislav Šulja is taking over management of the booking platform and wants to drive international growth.
The exits of the year
This year, many founders sold their startups. However, the Munich startup scene saw no IPOs in 2023. We’ve compiled the most important exits of the year for you.
AI assistant Askbrian acquired by Think-Cell
Wolfratshausen startup Askbrian has developed a digital assistant that communicates with its users using natural language. Berlin-based company Think-Cell has now acquired Askbrian.
Magazino becomes part of Jungheinrich
Munich robotics startup Magazino is being acquired by Jungheinrich. The Hamburg-based intralogistics company is acquiring all shares from the founders and previous shareholders. The transaction became effective immediately upon signature.
Munich Re acquires insurtech startup Apinity from Allianz incubator
Munich-based insurtech Apinity helps companies scale, manage, and monetize their APIs. The startup, which started as a business division of the Allianz incubator Syncier, has now been acquired by Munich Re.